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Wednesday, February 6, 2013 687aare also downregulated. MSCs cultured on the embedded-fiber, soft matrix
exhibit many similarities to cells on rigid substrates: higher SMA but lower
collagen type I protein expression. Phosphorylation at serine-1943 (S1943)
of non-muscle myosin IIA, which deactivates stress fiber assembly, is de-
creased on both fibrosis-like and rigid substrates but almost twice higher on
a soft substrate. TGFb is found to induce S1943 phosphorylation and SMA
and collagen type I production. Surprisingly, inhibition of the TGFb pathway
perturbs matrix expression but not SMA, suggesting a response that is unique
from those of myofibroblasts. Furthermore, these ‘myo-MSCs’ hint that, unlike
myofibroblasts, they do not become hyper-contractile. This supports the notion
that MSC engraftment into wounded tissues suppresses fibrosis, highlighting
the promise of these cells in restoring normal tissue function.
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As cell-based therapy is increasingly becoming a reality there is a need to gen-
erate large number of cells (10-12 billions) with small volume footprint and
rapidly. One of the ways to realize this is to grow cells on microcarriers where
cells adhere to microcarriers and then start doubling on the surface. Here we
present a mathematical model that captures various aspects of cell growth on
these surfaces. Specifically we present details of two models (i) continuum
model that helps us determine cell specific and surface specific parameters
from experimental data of cell growth on flat surfaces and (ii) discrete model
that provides information on number of occupied sites and inhibited sites at
an individual bead level. Further the discrete model captures some interesting
aspects of cell scale up related to bead to bead transfer of cells. The model eval-
uates different scenarios like bead size, bead size to cell size, initial cell seeding
and distribution of seeding and further evaluates if mixing could potentially
enhance cell scale up.
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Tissue injury results in induction of endogenous electric field (EF) that
mediates biophysical interactions in the ionic wound environment, which
play a crucial role in tissue repair. Externally applied EF may therefore provide
a promising therapeutic approach for wound healing; however, information on
EF-cell interactions in the wound is limited. This research presents a combined
theoretical-experimental approach to study EF interactions with fibroblasts
(FBs) in vitro. The cell is modeled as a membrane-enclosed hemisphere
surrounded by electrolyte. Maxwell’s equations are solved numerically
(ANSYS-HFSS) to obtain 3D EF distribution inside and near the cell subjected
to an externally applied EF. Experimentally, FBs were exposed to the EF in
a parallel-plate capacitor for 72 hours; cell morphology, proliferation and
expression of pro-angiogenic growth factors
were assessed. Theoretical results demon-
strate the spatially-varying EF distribution
in the cell membrane, where induced poten-
tial may be sufficient to regulate voltage-
gated ion channel activation. Cell exposure
to the EF resulted in significantly increased
expression of placenta growth factor but no
change in other parameters. Ongoing studies
will determine the role of EF-mediated acti-
vation of voltage-gated channels in the cel-
lular response, contributing to development
of EF-based therapies for tissue repair.
3534-Pos Board B689
Improving Longevity of Fibrin Sealant in a Proteolytic Environment
Binoy (Ben) K. Bordoloi1, Rodney L. Eisenberg2, Nayan J. Sarma3.
1Bordoloi Biotech, LLC, Bridgewater, NJ, USA, 2Frontier BioPharm, LLC,
Richmond, KY, USA, 3Consultant (Post-Doctoral Research Associate at
Washington University), St Louis, MO, USA.
Fibrin sealants are used in surgical procedures as an adjunct to sutures and sta-
ples to prevent fluid leakage and bleeding. These applications require extended
longevity of fibrin sealant. It takes about 2 weeks for a typical surgical wound
to heal, whereas fibrin sealant typically survives only 2 to 3 days in vivo due
to its degradation by proteases such as plasmin present in the tissue micro-
environment. Tranexamic acid (TA) is a well-known inhibitor of proteases
including plasmin present in the blood. However, water soluble TA rapidly dif-
fuses out of the sealant under in vivo conditions. Therefore, an investigationaimed to study the mechanism of sustained release of TA has been undertaken
using microspheres of an absorbable PLGA (poly-lactic-glycolic-acid) poly-
mer. TA particles of average dimension 3 micron are impregnated at a loading
of 5% and 30% in average 40 micron PLGA microspheres. These are verified
by Scanning Electron Microscopy / Energy Dispersive X-Ray spectroscopy.
Confocal Raman spectroscopy shows that TA is distributed desirably more to-
wards the core of the microsphere. Release study of TA by LC-MS using direct
auto-sampler injection into Mass Spectral detector with ESI MS positive ion
mode ionization shows that about 70% of TA from 5% TA Loaded / PLGA mi-
crospheres is released continuously over a period of 144 hours (or 6 days). Rate
of TA release significantly slows down after the initial 72 hours. A gravimetric
in vitromethod has been developed to monitor the degradation of the sealant in
a plasmin containing medium at pH 7.4 and 37 0C. The plasmin medium has
been changed each day continuously up to 4 days. The proof-of-principle of im-
proving longevity of fibrin sealant has been demonstrated with both 5% and
30% TA loaded / PLGA microspheres compared to the control.
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Aquaporins are water channel proteins with high water permeability and solute
rejection, which makes them promising for preparing high-performance biomi-
metic membranes. Despite the growing interest in aquaporin-based biomimetic
membranes (ABMs), it is challenging to produce robust and defect-free ABMs
that can be easily scaled up. We have constructed robust thin film composite
(TFC) ABMs with surface areas up to 600 cm2 prepared by interfacial polymer-
ization where Aquaporin Z-containing proteoliposomes were added to a m-phe-
nylene-diamine aqueous solution thereby creating a polymer-rich film on top of
a support membrane. Control membranes, either without aquaporins or with the
inactive AqpZ R189A mutant aquaporin served as controls. The separation per-
formance of the membranes was evaluated by cross-flow forward osmosis (FO)
and reverse osmosis (RO) tests. In RO the ABM achieved a water permeability
of ~ 4 L/(m2 h bar) with a NaCl rejection > 97% at an applied hydraulic pres-
sure of 5 bar. The water permeability was ~40% higher compared to a commer-
cial brackish water RO membrane (BW30) and an order of magnitude higher
compared to a seawater RO membrane (SW30HR). In FO, the ABMs had >
90% rejection for urea and a water permeability around 10 L/(m2h) with 2M
NaCl as draw solution. Our results demonstrate the feasibility of using aqua-
porin proteins in biomimetic membranes for technological applications.
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Interest in the development of biomimetic cell models is driven by its potential
to go beyond a purely descriptive picture of cellular processes towards a quan-
titative understanding and rigorous validation of theoretical modeling. Cells are
exceptionally complex entities with a large variety of active and passive com-
ponents. A quantitative investigation of a specific process in such complex
environment is prohibitively challenging. In a biomimetic system like a giant
unilamellar vesicle on the other hand the key components of a specific process
can be studied isolated from other factors. In this way, it is possible to achieve
quantitative information and that will allow us to discover the governing prin-
ciples of the processes involved.
Recently we introduced a protocol to prepare advanced cell models from giant
unilamellar vesicles for studies of membrane processes that involve transmem-
brane proteins. We further showed that specific functionalization permits to use
those biomimetic systems in a lab-on-a-chip scenario. [1] Building on this de-
velopment, we present here a novel approach that allows us to realize a mimetic
cell model that includes in situ protein synthesis and active membrane translo-
cation. Giant unilamellar vesicles were prepared starting from eukaryotic cell
lysates containing both the eukaryotic protein synthesis machinery as well as
the translocon that is required to integrate proteins into membranes. Our soft
methodology for vesicle preparation on agarose-coated surfaces allowed us
to keep the translocon fully functional. The advantage of in situ expression
